Short answer
ASPEN AEROGELS INC (ASPN) filed its Q1 2026 10-Q quarterly report on May 8, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $38M (down 51.9% year over year) with net income of −$24M.
Q1 2026 key financials · XBRL
- Revenue
- $38M
- −51.9% YoY
- Net income
- −$24M
- +92.1% YoY
- Operating margin
- -55.0%
- Gross margin
- 11.3%
- EPS (diluted)
- −$0.29
- +92.1% YoY
Source: XBRL data from the ASPEN AEROGELS INC (ASPN) Q1 2026 10-Q on SEC EDGAR. USD.
ASPEN AEROGELS INC Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Newly heightened facility risk: April 8, 2026 explosion damaged production space and halted East Providence operations
- Operational risk: East Providence facility remained offline as of May 8, 2026, with staged restart dependent on safety reviews
- Regulatory risk: Restart requires coordination with local and state agencies and relevant authorities
- Capacity risk: Older, smaller emissions-control unit limits East Providence production after January 2026 fire
- Concentration risk: East Providence and one China external facility supply customer demand; alternatives may be unavailable
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ASPEN AEROGELS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.